• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.非酒精性脂肪性肝病患者中瘦人、超重和肥胖者的游离脂肪酸谱:一项病例对照研究。
Lipids Health Dis. 2017 Sep 4;16(1):165. doi: 10.1186/s12944-017-0551-1.
2
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
3
Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.循环不饱和脂肪酸描绘肥胖个体的代谢状态。
EBioMedicine. 2015 Sep 6;2(10):1513-22. doi: 10.1016/j.ebiom.2015.09.004. eCollection 2015 Oct.
4
Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.瘦素型非酒精性脂肪性肝病:与代谢失调和心血管风险的相关性——一项单中心横断面研究。
Clin Transl Gastroenterol. 2021 Apr 5;12(4):e00326. doi: 10.14309/ctg.0000000000000326.
5
Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.瘦型非酒精性脂肪性肝病(NAFLD)患者的临床特征和代谢特征及其与肥胖和超重 NAFLD 的比较。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
6
Both WHR and FLI as Better Algorithms for Both Lean and Overweight/Obese NAFLD in a Chinese Population.WHR 和 FLI 都是中国人群中非酒精性脂肪性肝病(NAFLD)中瘦型和超重/肥胖患者的更好算法。
J Clin Gastroenterol. 2019 Jul;53(6):e253-e260. doi: 10.1097/MCG.0000000000001089.
7
Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.脂联素-瘦素比值可早期发现非肥胖型非酒精性脂肪性肝病,与胰岛素抵抗无关。
Ann Med. 2023 Dec;55(1):634-642. doi: 10.1080/07853890.2023.2179106.
8
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.非酒精性脂肪性肝病患者和健康对照者口服脂肪负荷后不同的血清游离脂肪酸谱。
Int J Mol Sci. 2016 Mar 31;17(4):479. doi: 10.3390/ijms17040479.
9
Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.非肥胖人群中非酒精性脂肪性肝病的临床特征。
Obes Facts. 2023;16(5):427-434. doi: 10.1159/000530845. Epub 2023 May 22.
10
Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.超重和肥胖非酒精性脂肪性肝病患者经体重调整的口服脂肪耐量试验后成纤维细胞生长因子19及胆汁酸合成的反应:一项非随机对照试验
BMC Gastroenterol. 2018 Jun 4;18(1):76. doi: 10.1186/s12876-018-0805-z.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
Defective lymphatic vasculature in obesity.肥胖中存在缺陷的淋巴管系统。
Obes Rev. 2025 Aug;26(8):e13922. doi: 10.1111/obr.13922. Epub 2025 Mar 27.
3
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.代谢功能障碍相关脂肪性肝病引起的抗氧化系统变化:综述
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
4
The Efficacy of ssp. Supplementation in Managing Body Weight and Blood Lipids of People with Overweight: A Randomized Pilot Trial.特定菌株补充剂对超重人群体重和血脂管理的疗效:一项随机试点试验
Metabolites. 2024 Feb 16;14(2):129. doi: 10.3390/metabo14020129.
5
GC/MS and LC/MS serum metabolomic analysis of Chinese LN patients.中国 LN 患者的 GC/MS 和 LC/MS 血清代谢组学分析。
Sci Rep. 2024 Jan 17;14(1):1523. doi: 10.1038/s41598-024-52137-w.
6
Fibroblast Growth Factor 21: A More Effective Biomarker Than Free Fatty Acids and Other Insulin Sensitivity Measures for Predicting Non-alcoholic Fatty Liver Disease in Saudi Arabian Type 2 Diabetes Patients.成纤维细胞生长因子21:在预测沙特阿拉伯2型糖尿病患者非酒精性脂肪性肝病方面,比游离脂肪酸及其他胰岛素敏感性指标更有效的生物标志物。
Cureus. 2023 Dec 14;15(12):e50524. doi: 10.7759/cureus.50524. eCollection 2023 Dec.
7
High maternal adiposity during pregnancy programs an imbalance in the lipidome and predisposes to diet-induced hepatosteatosis in the offspring.孕期母体肥胖会导致脂质组失衡,并使后代易患饮食诱导的肝脂肪变性。
Biosci Rep. 2023 Oct 31;43(10). doi: 10.1042/BSR20231060.
8
Cellular heterogeneity and plasticity during NAFLD progression.非酒精性脂肪性肝病进展过程中的细胞异质性和可塑性。
Front Mol Biosci. 2023 Aug 11;10:1221669. doi: 10.3389/fmolb.2023.1221669. eCollection 2023.
9
Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling.磷脂酰肌醇和细胞内钙离子信号转导:磷脂酰肌醇与钙离子偶联作为细胞信号转导负调节剂的新见解。
Exp Mol Med. 2023 Aug;55(8):1702-1712. doi: 10.1038/s12276-023-01067-0. Epub 2023 Aug 1.
10
Metabolic and Risk Profiles of Lean and Non-Lean Hepatic Steatosis among US Adults.美国成年人中瘦型和非瘦型非酒精性脂肪性肝病的代谢和风险特征。
Nutrients. 2023 Jun 23;15(13):2856. doi: 10.3390/nu15132856.

本文引用的文献

1
Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.撤稿与重新发表:地中海饮食对心血管疾病的一级预防。《新英格兰医学杂志》2013年;368卷:1279 - 1290页。
N Engl J Med. 2018 Jun 21;378(25):2441-2442. doi: 10.1056/NEJMc1806491. Epub 2018 Jun 13.
2
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
3
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.棕榈油酸在脂肪肝疾病中升高,并反映肝脏脂肪生成。
Am J Clin Nutr. 2015 Jan;101(1):34-43. doi: 10.3945/ajcn.114.092262. Epub 2014 Nov 19.
4
Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting.溶质载体家族 7a3a 的基因缺失导致禁食状态下斑马鱼的肝脂肪变性。
Hepatology. 2014 Dec;60(6):1929-41. doi: 10.1002/hep.27356. Epub 2014 Nov 4.
5
Manifestations of fasting-induced fatty liver and rapid recovery from steatosis in voles fed lard or flaxseed oil lipids.食用猪油或亚麻籽油脂质的田鼠的禁食诱导性脂肪肝表现和脂肪变性的快速恢复。
Nutrients. 2013 Oct 22;5(10):4211-30. doi: 10.3390/nu5104211.
6
Saturated free fatty acid sodium palmitate-induced lipoapoptosis by targeting glycogen synthase kinase-3β activation in human liver cells.饱和游离脂肪酸棕榈酸钠通过靶向糖原合酶激酶-3β激活诱导人肝细胞脂肪凋亡。
Dig Dis Sci. 2014 Feb;59(2):346-57. doi: 10.1007/s10620-013-2896-2. Epub 2013 Oct 17.
7
The global NAFLD epidemic.全球非酒精性脂肪性肝病流行状况。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17.
8
The Gordian Knot of dysbiosis, obesity and NAFLD.肠道菌群失调、肥胖和非酒精性脂肪性肝病之间的不解之结。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):637-44. doi: 10.1038/nrgastro.2013.146. Epub 2013 Aug 20.
9
'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease.用于心血管疾病一级预防的“地中海式”饮食模式。
Cochrane Database Syst Rev. 2013 Aug 12(8):CD009825. doi: 10.1002/14651858.CD009825.pub2.
10
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.游离脂肪酸抑制小异二聚体伴侣(SHP)的激活,脂联素可拮抗胆汁酸诱导的非酒精性脂肪性肝炎超肥胖患者的肝损伤。
Hepatology. 2013 Apr;57(4):1394-406. doi: 10.1002/hep.26225.

非酒精性脂肪性肝病患者中瘦人、超重和肥胖者的游离脂肪酸谱:一项病例对照研究。

Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.

机构信息

Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, 157 Baojian Street, Nangang District, Harbin, Heilongjiang Province, 150081, China.

STD & AIDS Center, Harbin Center for Disease Control and Prevention, Harbin, Heilongjiang Province, 150056, China.

出版信息

Lipids Health Dis. 2017 Sep 4;16(1):165. doi: 10.1186/s12944-017-0551-1.

DOI:10.1186/s12944-017-0551-1
PMID:28870233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5584533/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) given its association with obesity and diabetes may perhaps exert distinct free fatty acids (FFA) pattern, but the understanding of this phenomenon is limited. To this effect, we evaluated FFA profiles among healthy subjects and NAFLD patients stratified by body weight, to identify FFA valuable for early diagnosis of NAFLD.

METHODS

Serum FFA profiles of healthy and NAFLD (lean, overweight and obese) subjects was determined using gas chromatography-mass spectrometry (GC-MS) and distinctions in FFA patterns were evaluated using one-way ANOVA while Receiver operating characteristics (ROC) and logistic regression models were used to explore FFA significant for diagnosing NAFLD.

RESULTS

NAFLD patients presented significantly higher (P < 0.05) serum FFA profiles compared to healthy controls (HC). While total FFA profiles were insignificantly different between lean (2093.33 ± 558.11 μg/ml) and overweight (2420.81 ± 555.18 μg/ml) NAFLD patients, obese NAFLD (2739.01 ± 810.35 μg/ml) presented most significantly elevated (P < 0.05) total FFA profiles compared with HC. Of the four FFA; myristic acid (14:0), palmitoleic acid (16:1), γ-linolenic acid (γ-18:3) and cis-7,10,13,16,19-docosapentaenoic acid (22:5), selected in ROC analysis given their high Youden's index and AUC, only 14:0; 5.58(1.37, 22.76) and 16:1; 4.36(1.34, 14.13) had statistical significant odd ratios.

CONCLUSION

Our findings suggest 14:0 and 16:1 are promising for early diagnosis of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)与肥胖和糖尿病有关,其游离脂肪酸(FFA)模式可能有所不同,但对这一现象的了解有限。为此,我们评估了按体重分层的健康受试者和 NAFLD 患者的 FFA 谱,以确定对 NAFLD 早期诊断有价值的 FFA。

方法

采用气相色谱-质谱联用(GC-MS)法测定健康受试者和 NAFLD(瘦、超重和肥胖)患者的血清 FFA 谱,采用单因素方差分析评估 FFA 谱的差异,采用受试者工作特征(ROC)和逻辑回归模型探讨对诊断 NAFLD 有意义的 FFA。

结果

与健康对照组(HC)相比,NAFLD 患者的血清 FFA 谱显著升高(P<0.05)。虽然瘦型(2093.33±558.11μg/ml)和超重型(2420.81±555.18μg/ml)NAFLD 患者的总 FFA 谱无显著差异,但肥胖型 NAFLD(2739.01±810.35μg/ml)与 HC 相比,总 FFA 谱显著升高(P<0.05)。在 4 种 FFA 中,选择 14:0、16:1、γ-亚麻酸(γ-18:3)和顺式-7,10,13,16,19-二十二碳五烯酸(22:5)进行 ROC 分析,因为它们具有较高的 Youden 指数和 AUC,只有 14:0(5.58[1.37, 22.76])和 16:1(4.36[1.34, 14.13])具有统计学显著的优势比。

结论

我们的研究结果表明,14:0 和 16:1 对 NAFLD 的早期诊断具有较大潜力。